| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
A nomogram predicting 10-year life expectancy in candidates for radical prostatectomy or radiotherapy for prostate cancer.
|
J Clin Oncol
|
2007
|
4.37
|
|
2
|
A non-cancer-related survival benefit is associated with partial nephrectomy.
|
Eur Urol
|
2011
|
3.18
|
|
3
|
Comparison of mortality outcomes after radical prostatectomy versus radiotherapy in patients with localized prostate cancer: a population-based analysis.
|
Int J Urol
|
2012
|
3.17
|
|
4
|
Cancer-specific and other-cause mortality after radical prostatectomy versus observation in patients with prostate cancer: competing-risks analysis of a large North American population-based cohort.
|
Eur Urol
|
2011
|
3.07
|
|
5
|
The rate of secondary malignancies after radical prostatectomy versus external beam radiation therapy for localized prostate cancer: a population-based study on 17,845 patients.
|
Int J Radiat Oncol Biol Phys
|
2010
|
3.06
|
|
6
|
Perioperative mortality is significantly greater in septuagenarian and octogenarian patients treated with radical cystectomy for urothelial carcinoma of the bladder.
|
Urology
|
2011
|
2.76
|
|
7
|
Chronic kidney disease after nephrectomy in patients with small renal masses: a retrospective observational analysis.
|
Eur Urol
|
2012
|
2.45
|
|
8
|
Age-adjusted incidence, mortality, and survival rates of stage-specific renal cell carcinoma in North America: a trend analysis.
|
Eur Urol
|
2010
|
2.38
|
|
9
|
Repeated intravesical instillations of an adenoviral vector in patients with locally advanced bladder cancer: a phase I study of p53 gene therapy.
|
J Clin Oncol
|
2003
|
2.30
|
|
10
|
Robot-assisted versus open radical prostatectomy: the differential effect of regionalization, procedure volume and operative approach.
|
J Urol
|
2012
|
2.22
|
|
11
|
Propensity-score-matched comparison of perioperative outcomes between open and laparoscopic nephroureterectomy: a national series.
|
Eur Urol
|
2011
|
2.20
|
|
12
|
Head-to-head comparison of three commonly used preoperative tools for prediction of lymph node invasion at radical prostatectomy.
|
Urology
|
2011
|
2.20
|
|
13
|
A competing-risks analysis of survival after alternative treatment modalities for prostate cancer patients: 1988-2006.
|
Eur Urol
|
2010
|
2.13
|
|
14
|
Comparison of partial vs radical nephrectomy with regard to other-cause mortality in T1 renal cell carcinoma among patients aged ≥75 years with multiple comorbidities.
|
BJU Int
|
2012
|
2.10
|
|
15
|
Multi-institutional validation of a new renal cancer-specific survival nomogram.
|
J Clin Oncol
|
2007
|
2.09
|
|
16
|
Pelvic lymph node dissection for prostate cancer: adherence and accuracy of the recent guidelines.
|
Int J Urol
|
2012
|
2.08
|
|
17
|
Lymph node count threshold for optimal pelvic lymph node staging in prostate cancer.
|
Int J Urol
|
2012
|
2.08
|
|
18
|
Prostate cancer-specific survival in men treated with hormonal therapy after failure of radical prostatectomy.
|
Eur Urol
|
2006
|
2.07
|
|
19
|
Comparative study of inguinal hernia repair after radical prostatectomy, prostate biopsy, transurethral resection of the prostate or pelvic lymph node dissection.
|
J Urol
|
2010
|
2.05
|
|
20
|
Higher perioperative morbidity and in-hospital mortality in patients with end-stage renal disease undergoing nephrectomy for non-metastatic kidney cancer: a population-based analysis.
|
BJU Int
|
2012
|
2.03
|
|
21
|
Blood transfusions in radical prostatectomy: a contemporary population-based analysis.
|
Urology
|
2012
|
2.03
|
|
22
|
High provider volume is associated with lower rate of secondary therapies after definitive radiotherapy for localized prostate cancer.
|
Eur Urol
|
2007
|
2.02
|
|
23
|
Critical assessment of the European Association of Urology guideline indications for pelvic lymph node dissection at radical prostatectomy.
|
BJU Int
|
2011
|
1.99
|
|
24
|
Neoadjuvant sutent induction therapy may effectively down-stage renal cell carcinoma atrial thrombi.
|
Eur Urol
|
2007
|
1.96
|
|
25
|
Segmental ureterectomy can safely be performed in patients with transitional cell carcinoma of the ureter.
|
J Urol
|
2010
|
1.91
|
|
26
|
Toxicities associated with the administration of sorafenib, sunitinib, and temsirolimus and their management in patients with metastatic renal cell carcinoma.
|
Eur Urol
|
2007
|
1.90
|
|
27
|
Head-to-head comparison of the three most commonly used preoperative models for prediction of biochemical recurrence after radical prostatectomy.
|
Eur Urol
|
2009
|
1.83
|
|
28
|
25-year prostate cancer control and survival outcomes: a 40-year radical prostatectomy single institution series.
|
J Urol
|
2006
|
1.82
|
|
29
|
High radical prostatectomy surgical volume is related to lower radical prostatectomy total hospital charges.
|
Eur Urol
|
2006
|
1.76
|
|
30
|
Tumor size is a determinant of the rate of stage T1 renal cell cancer synchronous metastasis.
|
J Urol
|
2009
|
1.73
|
|
31
|
Clinicians are poor raters of life-expectancy before radical prostatectomy or definitive radiotherapy for localized prostate cancer.
|
BJU Int
|
2007
|
1.68
|
|
32
|
A critical appraisal of the value of lymph node dissection at nephroureterectomy for upper tract urothelial carcinoma.
|
Urology
|
2009
|
1.68
|
|
33
|
Marital status: a gender-independent risk factor for poorer survival after radical cystectomy.
|
BJU Int
|
2012
|
1.64
|
|
34
|
Highly predictive survival nomogram after upper urinary tract urothelial carcinoma.
|
Cancer
|
2010
|
1.61
|
|
35
|
A proposal for reclassification of the Fuhrman grading system in patients with clear cell renal cell carcinoma.
|
Eur Urol
|
2009
|
1.61
|
|
36
|
Partial cystectomy does not undermine cancer control in appropriately selected patients with urothelial carcinoma of the bladder: a population-based matched analysist.
|
Urology
|
2009
|
1.58
|
|
37
|
Nephron-sparing surgery is equally effective to radical nephrectomy for T1BN0M0 renal cell carcinoma: a population-based assessment.
|
Urology
|
2009
|
1.58
|
|
38
|
Annual surgical caseload and open radical prostatectomy outcomes: improving temporal trends.
|
J Urol
|
2010
|
1.57
|
|
39
|
A stage-for-stage and grade-for-grade analysis of cancer-specific mortality rates in renal cell carcinoma according to age: a competing-risks regression analysis.
|
Eur Urol
|
2011
|
1.57
|
|
40
|
External validation of postoperative nomograms for prediction of all-cause mortality, cancer-specific mortality, and recurrence in patients with urothelial carcinoma of the bladder.
|
Eur Urol
|
2011
|
1.56
|
|
41
|
Cytoreductive partial nephrectomy does not undermine cancer control in metastatic renal cell carcinoma: a population-based study.
|
Urology
|
2008
|
1.55
|
|
42
|
Thirty-day mortality after nephrectomy: clinical implications for informed consent.
|
Eur Urol
|
2008
|
1.53
|
|
43
|
Poor overall survival in septa- and octogenarian patients after radical prostatectomy and radiotherapy for prostate cancer: a population-based study of 6183 men.
|
Eur Urol
|
2007
|
1.51
|
|
44
|
Survival after radical prostatectomy and radiotherapy for prostate cancer: a population-based study.
|
Can Urol Assoc J
|
2009
|
1.51
|
|
45
|
Radical versus partial nephrectomy: effect on overall and noncancer mortality.
|
Cancer
|
2009
|
1.51
|
|
46
|
Is robot-assisted radical prostatectomy safe in men with high-risk prostate cancer? Assessment of perioperative outcomes, positive surgical margins, and use of additional cancer treatments.
|
J Endourol
|
2014
|
1.50
|
|
47
|
Partial and radical nephrectomy provide comparable long-term cancer control for T1b renal cell carcinoma.
|
Int J Urol
|
2013
|
1.50
|
|
48
|
Currently used criteria for active surveillance in men with low-risk prostate cancer: an analysis of pathologic features.
|
Cancer
|
2008
|
1.48
|
|
49
|
Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen.
|
J Urol
|
2005
|
1.45
|
|
50
|
Open radical prostatectomy in the elderly: a case for concern?
|
BJU Int
|
2011
|
1.45
|
|
51
|
Nodal involvement at nephrectomy is associated with worse survival: a stage-for-stage and grade-for-grade analysis.
|
Int J Urol
|
2012
|
1.45
|
|
52
|
A contemporary population-based assessment of the rate of lymph node dissection for penile carcinoma.
|
Ann Surg Oncol
|
2010
|
1.43
|
|
53
|
C-reactive protein is an informative predictor of renal cell carcinoma-specific mortality: a European study of 313 patients.
|
Cancer
|
2007
|
1.43
|
|
54
|
Biopsy core number represents one of foremost predictors of clinically significant gleason sum upgrading in patients with low-risk prostate cancer.
|
Urology
|
2009
|
1.42
|
|
55
|
Benefit in regionalization of care for patients treated with nephrectomy: a Nationwide Inpatient Sample.
|
World J Urol
|
2014
|
1.41
|
|
56
|
Leapfrog volume thresholds and perioperative complications after radical prostatectomy.
|
Cancer
|
2012
|
1.40
|
|
57
|
The prognostic value of erythrocyte polyamine in the post-nephrectomy stratification of renal cell carcinoma specific mortality.
|
J Urol
|
2009
|
1.40
|
|
58
|
Extent of lymphadenectomy does not improve the survival of patients with renal cell carcinoma and nodal metastases: biases associated with the handling of missing data.
|
BJU Int
|
2013
|
1.39
|
|
59
|
Annual prostatectomy volume is related to rectal laceration rate after radical prostatectomy.
|
Urology
|
2012
|
1.38
|
|
60
|
The 2002 AJCC pT2 substages confer no prognostic information on the rate of biochemical recurrence after radical prostatectomy.
|
Eur Urol
|
2006
|
1.38
|
|
61
|
Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder.
|
J Urol
|
2006
|
1.38
|
|
62
|
Distribution of metastatic sites in patients with prostate cancer: A population-based analysis.
|
Prostate
|
2013
|
1.36
|
|
63
|
A population based assessment of perioperative mortality after cystectomy for bladder cancer.
|
J Urol
|
2009
|
1.35
|
|
64
|
Should bladder cuff excision remain the standard of care at nephroureterectomy in patients with urothelial carcinoma of the renal pelvis? A population-based study.
|
Eur Urol
|
2009
|
1.33
|
|
65
|
The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation.
|
Eur J Cancer
|
2010
|
1.30
|
|
66
|
Population-based assessment of survival after cytoreductive nephrectomy versus no surgery in patients with metastatic renal cell carcinoma.
|
Urology
|
2008
|
1.26
|
|
67
|
Nomograms including nuclear matrix protein 22 for prediction of disease recurrence and progression in patients with Ta, T1 or CIS transitional cell carcinoma of the bladder.
|
J Urol
|
2005
|
1.25
|
|
68
|
Treatment of metastatic renal cell carcinoma.
|
Nat Rev Urol
|
2010
|
1.24
|
|
69
|
A critical assessment of the prognostic value of clear cell, papillary and chromophobe histological subtypes in renal cell carcinoma: a population-based study.
|
BJU Int
|
2008
|
1.20
|
|
70
|
External validation of a biomarker-based preoperative nomogram predicts biochemical recurrence after radical prostatectomy.
|
J Clin Oncol
|
2008
|
1.18
|
|
71
|
Accuracy of life tables in predicting overall survival in patients after radical prostatectomy.
|
BJU Int
|
2008
|
1.18
|
|
72
|
Disparities in access to care at high-volume institutions for uro-oncologic procedures.
|
Cancer
|
2012
|
1.17
|
|
73
|
Incidence, survival and mortality rates of stage-specific bladder cancer in United States: a trend analysis.
|
Cancer Epidemiol
|
2013
|
1.16
|
|
74
|
Surgical volume is related to the rate of positive surgical margins at radical prostatectomy in European patients.
|
BJU Int
|
2006
|
1.15
|
|
75
|
A population-based assessment of perioperative mortality after nephroureterectomy for upper-tract urothelial carcinoma.
|
Urology
|
2009
|
1.12
|
|
76
|
Mortality at 120 days after prostatic biopsy: a population-based study of 22,175 men.
|
Int J Cancer
|
2008
|
1.12
|
|
77
|
Comparison of stage migration patterns between Europe and the USA: an analysis of 11 350 men treated with radical prostatectomy for prostate cancer.
|
BJU Int
|
2008
|
1.11
|
|
78
|
Prostate volume and adverse prostate cancer features: fact not artifact.
|
Eur J Cancer
|
2007
|
1.09
|
|
79
|
Treatment management of small renal masses in the 21st century: a paradigm shift.
|
Ann Surg Oncol
|
2012
|
1.07
|
|
80
|
Precystectomy nomogram for prediction of advanced bladder cancer stage.
|
Eur Urol
|
2006
|
1.07
|
|
81
|
Racial disparities and socioeconomic status in men diagnosed with testicular germ cell tumors: a survival analysis.
|
Cancer
|
2011
|
1.06
|
|
82
|
Location of the primary tumor is not an independent predictor of cancer specific mortality in patients with upper urinary tract urothelial carcinoma.
|
J Urol
|
2009
|
1.06
|
|
83
|
A population-based analysis of the rate of cytoreductive nephrectomy for metastatic renal cell carcinoma in the United States.
|
Urology
|
2009
|
1.04
|
|
84
|
A prospective randomized trial of 1-day versus 3-day antibiotic prophylaxis for transrectal ultrasound guided prostate biopsy.
|
Can J Urol
|
2004
|
1.03
|
|
85
|
Age at diagnosis is a determinant factor of renal cell carcinoma-specific survival in patients treated with nephrectomy.
|
Can Urol Assoc J
|
2008
|
1.03
|
|
86
|
Conditional survival predictions after nephrectomy for renal cell carcinoma.
|
J Urol
|
2009
|
1.02
|
|
87
|
Management of hepatic granulomatous tuberculosis complicating intravesical BCG for superficial bladder cancer.
|
Can Urol Assoc J
|
2007
|
1.02
|
|
88
|
A population-based competing-risks analysis of the survival of patients treated with radical cystectomy for bladder cancer.
|
Cancer
|
2010
|
1.00
|
|
89
|
Radical prostatectomy at academic versus nonacademic institutions: a population based analysis.
|
J Urol
|
2011
|
1.00
|
|
90
|
Nephroureterectomy and segmental ureterectomy in the treatment of invasive upper tract urothelial carcinoma: a population-based study of 2299 patients.
|
Eur J Cancer
|
2009
|
0.99
|
|
91
|
Mortality and morbidity after cytoreductive nephrectomy for metastatic renal cell carcinoma: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.99
|
|
92
|
Morbidity and mortality of radical prostatectomy differs by insurance status.
|
Cancer
|
2011
|
0.99
|
|
93
|
The effect of comorbidity and socioeconomic status on sexual and urinary function and on general health-related quality of life in men treated with radical prostatectomy for localized prostate cancer.
|
J Sex Med
|
2008
|
0.99
|
|
94
|
Race affects access to nephrectomy but not survival in renal cell carcinoma.
|
BJU Int
|
2008
|
0.98
|
|
95
|
A review of integrated staging systems for renal cell carcinoma.
|
Eur Urol
|
2012
|
0.98
|
|
96
|
Gender-related differences in patients with stage I to III upper tract urothelial carcinoma: results from the Surveillance, Epidemiology, and End Results database.
|
Urology
|
2009
|
0.98
|
|
97
|
Biochemical recurrence after radical prostatectomy: multiplicative interaction between surgical margin status and pathological stage.
|
J Urol
|
2010
|
0.95
|
|
98
|
External validation of the updated Partin tables in a cohort of North American men.
|
J Urol
|
2008
|
0.95
|
|
99
|
Inhibition of tumorigenicity and metastasis of human bladder cancer growing in athymic mice by interferon-beta gene therapy results partially from various antiangiogenic effects including endothelial cell apoptosis.
|
Clin Cancer Res
|
2002
|
0.95
|
|
100
|
Body mass index does not predict prostate-specific antigen or percent free prostate-specific antigen in men undergoing prostate cancer screening.
|
Eur J Cancer
|
2007
|
0.94
|
|
101
|
Accuracy of life tables in predicting overall survival in candidates for radiotherapy for prostate cancer.
|
Int J Radiat Oncol Biol Phys
|
2007
|
0.94
|
|
102
|
Tumor grade improves the prognostic ability of American Joint Committee on Cancer stage in patients with penile carcinoma.
|
J Urol
|
2010
|
0.94
|
|
103
|
A simple and accurate model for prediction of cancer-specific mortality in patients treated with surgery for primary penile squamous cell carcinoma.
|
Clin Cancer Res
|
2009
|
0.93
|
|
104
|
Validation of 1997 Partin Tables' lymph node invasion predictions in men treated with radical prostatectomy in Montreal Quebec.
|
Can J Urol
|
2005
|
0.93
|
|
105
|
The effect of marital status on stage and survival of prostate cancer patients treated with radical prostatectomy: a population-based study.
|
Cancer Causes Control
|
2011
|
0.92
|
|
106
|
Population-based study of perioperative mortality after retroperitoneal lymphadenectomy for nonseminomatous testicular germ cell tumors.
|
Urology
|
2009
|
0.92
|
|
107
|
Assessment of cancer control outcomes in patients with high-risk renal cell carcinoma treated with partial nephrectomy.
|
Urology
|
2012
|
0.92
|
|
108
|
Validation of a nomogram for prediction of side specific extracapsular extension at radical prostatectomy.
|
J Urol
|
2006
|
0.91
|
|
109
|
A nomogram is more accurate than a regression tree in predicting lymph node invasion in prostate cancer.
|
BJU Int
|
2007
|
0.91
|
|
110
|
The role of bisphosphonates in hormone-refractory prostate cancer.
|
World J Urol
|
2005
|
0.91
|
|
111
|
A population-based analysis of the effect of marital status on overall and cancer-specific mortality in patients with squamous cell carcinoma of the penis.
|
Cancer Causes Control
|
2012
|
0.90
|
|
112
|
Cytoreductive nephrectomy in the elderly: a population-based cohort from the USA.
|
BJU Int
|
2011
|
0.90
|
|
113
|
Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
|
BJU Int
|
2008
|
0.90
|
|
114
|
A population-based comparison of cancer-control rates between radical and partial nephrectomy for T1A renal cell carcinoma.
|
Urology
|
2010
|
0.90
|
|
115
|
Can renal mass biopsy assessment of tumor grade be safely substituted for by a predictive model?
|
J Urol
|
2009
|
0.89
|
|
116
|
Survival benefit of radical prostatectomy in patients with localized prostate cancer: estimations of the number needed to treat according to tumor and patient characteristics.
|
J Urol
|
2012
|
0.89
|
|
117
|
Is a treatment delay in radical prostatectomy safe in individuals with low-risk prostate cancer?
|
J Sex Med
|
2012
|
0.89
|
|
118
|
Prognostic significance of lymph node invasion in patients with metastatic renal cell carcinoma: a population-based perspective.
|
Cancer
|
2009
|
0.88
|
|
119
|
A nomogram predicting metastatic progression after radical prostatectomy.
|
Int J Urol
|
2008
|
0.88
|
|
120
|
Competing-risks mortality after radiotherapy vs. observation for localized prostate cancer: a population-based study.
|
Int J Radiat Oncol Biol Phys
|
2012
|
0.88
|
|
121
|
Lewis-Sumner syndrome and Tangier disease.
|
Arch Neurol
|
2008
|
0.88
|
|
122
|
Improvement of racial disparities with respect to the utilization of minimally invasive radical prostatectomy in the United States.
|
Cancer
|
2011
|
0.87
|
|
123
|
The effect of insurance status on outcomes after partial nephrectomy.
|
Int Urol Nephrol
|
2011
|
0.87
|
|
124
|
Baseline renal function, ischaemia time and blood loss predict the rate of renal failure after partial nephrectomy.
|
BJU Int
|
2009
|
0.87
|
|
125
|
Robot-assisted vs. laparoscopic partial nephrectomy: utilization rates and perioperative outcomes.
|
Int Braz J Urol
|
2013
|
0.87
|
|
126
|
In-hospital mortality and failure-to-rescue rates after radical cystectomy.
|
BJU Int
|
2013
|
0.87
|
|
127
|
Stage-specific impact of pelvic lymph node dissection on survival in patients with non-metastatic bladder cancer treated with radical cystectomy.
|
BJU Int
|
2011
|
0.87
|
|
128
|
Tumor size improves the accuracy of TNM predictions in patients with renal cancer.
|
Eur Urol
|
2006
|
0.87
|
|
129
|
In-hospital mortality and failure to rescue after cytoreductive nephrectomy.
|
Eur Urol
|
2012
|
0.87
|
|
130
|
Impact of caseload on total hospital charges: a direct comparison between minimally invasive and open radical prostatectomy--a population based study.
|
J Urol
|
2011
|
0.87
|
|
131
|
Radical cystectomy for patients with pT4 urothelial carcinoma in a large population-based study.
|
BJU Int
|
2010
|
0.86
|
|
132
|
Conditional survival of patients with urothelial carcinoma of the urinary bladder treated with radical cystectomy.
|
Eur J Cancer
|
2011
|
0.86
|
|
133
|
A comparative population-based analysis of the rate of partial vs radical nephrectomy for clinically localized renal cell carcinoma.
|
BJU Int
|
2010
|
0.86
|
|
134
|
A nomogram predicting prostate cancer-specific mortality after radical prostatectomy.
|
Urol Int
|
2010
|
0.86
|
|
135
|
Impact of surgical experience on in-hospital complication rates in patients undergoing minimally invasive prostatectomy: a population-based study.
|
Ann Surg Oncol
|
2010
|
0.86
|
|
136
|
Multi-institutional external validation of seminal vesicle invasion nomograms: head-to-head comparison of Gallina nomogram versus 2007 Partin tables.
|
Int J Radiat Oncol Biol Phys
|
2008
|
0.86
|
|
137
|
Impact of chronic prostatitis-like symptoms on the quality of life in a large group of men.
|
BJU Int
|
2007
|
0.86
|
|
138
|
External validation of a nomogram predicting mortality in patients with adrenocortical carcinoma.
|
BJU Int
|
2009
|
0.85
|
|
139
|
Development and validation of a reference table for prediction of postoperative mortality rate in patients treated with radical cystectomy: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.85
|
|
140
|
Rates of open versus laparoscopic and partial versus radical nephrectomy for T1a renal cell carcinoma: a population-based evaluation.
|
Int J Urol
|
2013
|
0.85
|
|
141
|
Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer.
|
Eur Urol
|
2006
|
0.85
|
|
142
|
Patients with renal cell carcinoma nodal metastases can be accurately identified: external validation of a new nomogram.
|
Int J Cancer
|
2007
|
0.85
|
|
143
|
Effect of autologous blood transfusion on the rate of biochemical recurrence after radical prostatectomy.
|
BJU Int
|
2007
|
0.84
|
|
144
|
Partial versus radical nephrectomy in patients with adverse clinical or pathologic characteristics.
|
Urology
|
2009
|
0.84
|
|
145
|
Impact of academic affiliation on radical cystectomy outcomes in North America: A population-based study.
|
Can Urol Assoc J
|
2012
|
0.84
|
|
146
|
Development and external validation of a highly accurate nomogram for the prediction of perioperative mortality after transurethral resection of the prostate for benign prostatic hyperplasia.
|
J Urol
|
2009
|
0.84
|
|
147
|
Sociodemographic disparities in the treatment of small renal masses.
|
BJU Int
|
2013
|
0.83
|
|
148
|
The effect of gender on nephrectomy perioperative outcomes: a national survey.
|
Can J Urol
|
2012
|
0.83
|
|
149
|
Stage-specific effect of nodal metastases on survival in patients with non-metastatic renal cell carcinoma.
|
BJU Int
|
2008
|
0.83
|
|
150
|
Urinary cytology and nuclear matrix protein 22 in the detection of bladder cancer recurrence other than transitional cell carcinoma.
|
BJU Int
|
2008
|
0.83
|
|
151
|
Body mass index and its association with genitourinary disorders in men undergoing prostate cancer screening.
|
J Sex Med
|
2008
|
0.82
|
|
152
|
Effect of nodal metastases on cancer-specific mortality after cytoreductive nephrectomy.
|
Ann Surg Oncol
|
2012
|
0.82
|
|
153
|
Zonal origin of localized prostate cancer does not affect the rate of biochemical recurrence after radical prostatectomy.
|
Eur Urol
|
2006
|
0.82
|
|
154
|
Population-based external validation of a competing-risks nomogram for patients with localized renal cell carcinoma.
|
J Clin Oncol
|
2010
|
0.82
|
|
155
|
The Canadian Uro-Oncology Group multicentre phase II study of docetaxel administered every 3 weeks with prednisone in men with metastatic hormone-refractory prostate cancer progressing after mitoxantrone/prednisone.
|
BJU Int
|
2008
|
0.82
|
|
156
|
Validation of prostate cancer index and SF-12 short forms.
|
Can J Urol
|
2005
|
0.81
|
|
157
|
A population-based comparison of survival after nephrectomy vs nonsurgical management for small renal masses.
|
BJU Int
|
2009
|
0.81
|
|
158
|
High surgical volume is associated with a lower rate of secondary therapy after radical prostatectomy for localized prostate cancer.
|
BJU Int
|
2008
|
0.81
|
|
159
|
Patients with distant metastases from renal cell carcinoma can be accurately identified: external validation of a new nomogram.
|
BJU Int
|
2007
|
0.81
|
|
160
|
Decreasing rate and extent of lymph node staging in patients undergoing radical prostatectomy may undermine the rate of diagnosis of lymph node metastases in prostate cancer.
|
Eur Urol
|
2010
|
0.81
|
|
161
|
Pazopanib trial data cannot support first-line use.
|
Nat Rev Urol
|
2010
|
0.81
|
|
162
|
Exploration of health-related quality of life areas that may distinguish between continent diversion and ileal conduit patients.
|
Can J Urol
|
2005
|
0.81
|
|
163
|
A critical assessment of the value of lymph node dissection at radical prostatectomy: A population-based study.
|
Prostate
|
2011
|
0.81
|
|
164
|
An evidence-based guide to the selection of sequential therapies in metastatic renal cell carcinoma.
|
Ther Adv Urol
|
2013
|
0.81
|
|
165
|
Trends of retroperitoneal lymphadenectomy use in patients with nonseminomatous germ cell tumor of the testis: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.81
|
|
166
|
Benefit in regionalisation of care for patients treated with radical cystectomy: a nationwide inpatient sample analysis.
|
BJU Int
|
2013
|
0.80
|
|
167
|
An epidural abscess following transrectal ultrasound-guided biopsies of the prostate.
|
Can J Urol
|
2005
|
0.80
|
|
168
|
Conditional survival after nephrectomy for renal cell carcinoma (RCC): changes in future survival probability over time.
|
BJU Int
|
2013
|
0.80
|
|
169
|
Therapeutic approach to hormone-refractory prostate cancer.
|
Can J Urol
|
2006
|
0.80
|
|
170
|
A population-based assessment of the National Comprehensive Cancer Network practice guideline indications for pelvic lymph node dissection at radical prostatectomy.
|
BJU Int
|
2011
|
0.80
|
|
171
|
Prostate specific-antigen distribution in asymptomatic Canadian men with no clinical evidence of prostate cancer.
|
BJU Int
|
2006
|
0.80
|
|
172
|
A contemporary update on rates and management of toxicities of targeted therapies for metastatic renal cell carcinoma.
|
Cancer Treat Rev
|
2013
|
0.80
|
|
173
|
Adenoviral p53 gene transfer in human bladder cancer cell lines: cytotoxicity and synergy with cisplatin.
|
Urol Oncol
|
2003
|
0.80
|
|
174
|
Temporal stage and grade migration in surgically treated patients with upper tract urothelial carcinoma.
|
BJU Int
|
2009
|
0.80
|
|
175
|
Survival after radical cystectomy of non-bilharzial squamous cell carcinoma vs urothelial carcinoma: a competing-risks analysis.
|
BJU Int
|
2011
|
0.79
|
|
176
|
Hospital volume is a determinant of postoperative complications, blood transfusion and length of stay after radical or partial nephrectomy.
|
J Urol
|
2011
|
0.79
|
|
177
|
Does partial nephrectomy at an academic institution result in better outcomes?
|
World J Urol
|
2011
|
0.79
|
|
178
|
Effect of body mass index on prostate-specific antigen and percentage free prostate-specific antigen: results from a prostate cancer screening cohort of 1490 men.
|
Int J Urol
|
2008
|
0.79
|
|
179
|
Differences in histopathological and biochemical outcomes in patients with low Gleason score prostate cancer.
|
BJU Int
|
2009
|
0.78
|
|
180
|
Unilateral prostate cancer cannot be accurately predicted in low-risk patients.
|
Int J Radiat Oncol Biol Phys
|
2009
|
0.78
|
|
181
|
Population-based analysis of normal Total PSA and percentage of free/Total PSA values: results from screening cohort.
|
Urology
|
2009
|
0.78
|
|
182
|
Venous thromboembolism after radical prostatectomy: the effect of surgical caseload.
|
BJU Int
|
2012
|
0.78
|
|
183
|
Management of upper urinary tract urothelial carcinoma.
|
Expert Rev Anticancer Ther
|
2010
|
0.78
|
|
184
|
Distribution of prostate specific antigen (PSA) and percentage free PSA in a contemporary screening cohort with no evidence of prostate cancer.
|
BJU Int
|
2007
|
0.78
|
|
185
|
Sunitinib relieves renal cell carcinoma spinal cord compression.
|
Eur Urol
|
2006
|
0.78
|
|
186
|
The effect of comorbidities and socioeconomic status on sexual and urinary function in men undergoing prostate cancer screening.
|
J Sex Med
|
2008
|
0.78
|
|
187
|
Does histologic subtype affect oncologic outcomes after nephron-sparing surgery?
|
Urology
|
2009
|
0.78
|
|
188
|
Screening men for prostate cancer and colorectal cancer: is practice evidence-based?
|
Can J Urol
|
2007
|
0.78
|
|
189
|
Ejaculatory disorders may affect screening for prostate cancer.
|
J Urol
|
2007
|
0.78
|
|
190
|
Baseline prevalence of erectile dysfunction in a prostate cancer screening population.
|
J Sex Med
|
2007
|
0.78
|
|
191
|
Comparative study of inguinal hernia repair rates after radical prostatectomy or external beam radiotherapy.
|
Int J Radiat Oncol Biol Phys
|
2010
|
0.78
|
|
192
|
The presence of prostate cancer on saturation biopsy can be accurately predicted.
|
BJU Int
|
2009
|
0.77
|
|
193
|
Early detection of prostate cancer with ultrasound-guided systematic needle biopsy.
|
Can J Urol
|
2005
|
0.77
|
|
194
|
Adjuvant radiotherapy after radical prostatectomy shows no ability to improve rates of overall and cancer-specific survival in a matched case-control study.
|
BJU Int
|
2008
|
0.77
|
|
195
|
The prognostic value of erythrocyte polyamines in the preoperative evaluation of patients with renal cell carcinoma.
|
Eur J Cancer
|
2010
|
0.77
|
|
196
|
Bone health in men with prostate cancer: diagnostic and therapeutic considerations.
|
Can J Urol
|
2005
|
0.77
|
|
197
|
Nephrectomy improves the survival of patients with locally advanced renal cell carcinoma.
|
BJU Int
|
2008
|
0.77
|
|
198
|
The impact of surgical experience on total hospital charges for minimally invasive prostatectomy: a population-based study.
|
BJU Int
|
2010
|
0.76
|
|
199
|
Fuhrman grade [corrected] has no added value in prediction of mortality after partial or [corrected] radical nephrectomy for chromophobe renal cell carcinoma patients.
|
Mod Pathol
|
2013
|
0.76
|
|
200
|
Normal urinary and sexual function in men without evidence of prostate cancer from Montreal, Canada.
|
BJU Int
|
2006
|
0.76
|
|
201
|
Adenocarcinoma versus urothelial carcinoma of the urinary bladder: comparison between pathologic stage at radical cystectomy and cancer-specific mortality.
|
Urology
|
2010
|
0.76
|
|
202
|
Assessment of biochemical recurrence rate in patients with pathologically confirmed insignificant prostate cancer.
|
Urology
|
2008
|
0.76
|
|
203
|
Treatment of BCG failures with intravesical BCG/Interferon: the University of Montreal experience.
|
Can J Urol
|
2006
|
0.76
|
|
204
|
Discharge patterns after radical prostatectomy in the United States of America.
|
Urol Oncol
|
2011
|
0.76
|
|
205
|
Conditional survival predictions after surgery for patients with penile carcinoma.
|
Cancer
|
2011
|
0.76
|
|
206
|
The effect of surgical volume, age and comorbidities on 30-day mortality after radical prostatectomy: a population-based analysis of 9208 consecutive cases.
|
BJU Int
|
2008
|
0.76
|
|
207
|
Effect of the number of biopsy cores on prostate cancer detection and staging.
|
Future Oncol
|
2010
|
0.76
|
|
208
|
Node-positive renal cell carcinoma in the absence of distant metastases: predictors of cancer-specific mortality in a population-based cohort.
|
BJU Int
|
2011
|
0.75
|
|
209
|
The importance of pelvic lymph node dissection in the elderly population: implications for interpreting the 2010 National Comprehensive Cancer Network practice guidelines for bladder cancer treatment.
|
J Urol
|
2011
|
0.75
|
|
210
|
Rapid and Complete Remission of Metastatic Adrenocortical Carcinoma Persisting 10 Years After Treatment With Mitotane Monotherapy: Case Report and Review of the Literature.
|
Medicine (Baltimore)
|
2016
|
0.75
|
|
211
|
Dose escalation of second-line sunitinib results in rapid partial remission of multiple hepatic metastases.
|
Can Urol Assoc J
|
2009
|
0.75
|
|
212
|
Clinical experience and critical evaluation of the role of everolimus in advanced renal cell carcinoma.
|
Open Access J Urol
|
2011
|
0.75
|
|
213
|
Rebuttal from authors re: Edward M. Messing. Node positive renal cell cancer. Who can be helped? Eur Urol 2007;51:1477-8.
|
Eur Urol
|
2007
|
0.75
|
|
214
|
Nephrectomy improves survival in patients with invasion of adjacent viscera and absence of nodal metastases (stage T4N0 renal cell carcinoma).
|
BJU Int
|
2009
|
0.75
|
|
215
|
Surgical caseload is an important determinant of continent urinary diversion rate at radical cystectomy: a population-based study.
|
Ann Surg Oncol
|
2011
|
0.75
|
|
216
|
The effect of annual surgical caseload on the rates of in-hospital pneumonia and other in-hospital outcomes after radical prostatectomy.
|
Int Urol Nephrol
|
2011
|
0.75
|
|
217
|
Lower urinary tract symptoms affect one-third of men in a prostate cancer screening population.
|
J Endourol
|
2008
|
0.75
|
|
218
|
Hospital and surgical caseload are predictors of comprehensive surgical treatment for bladder cancer: a population based study.
|
J Urol
|
2011
|
0.75
|
|
219
|
Discharge patterns after radical cystectomy: contemporary trends in the United States.
|
J Urol
|
2012
|
0.75
|
|
220
|
Prostate cancer nomograms are superior to neural networks.
|
Can J Urol
|
2006
|
0.75
|
|
221
|
An analysis of patients with T2 renal cell carcinoma (RCC) according to tumour size: a population-based analysis.
|
BJU Int
|
2013
|
0.75
|
|
222
|
Thirty-day mortality after transurethral resection of the prostate in patients treated with androgen deprivation therapy.
|
J Endourol
|
2009
|
0.75
|